Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-09-20

Clinical Trial Update: Asthma Exacerbation and Helium-3 MRI [NA]

View source ↗

Summary

A clinical trial evaluating helium-3 MRI in asthma exacerbation sponsored by the University of Massachusetts Worcester has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Asthma Exacerbation | NA | Status: WITHDRAWN